1 week ago
Indian-Origin Doctor Leads New Liver Cancer Treatment Framework
A group of doctors created a guide for treating liver cancer.
The guide is called BEACON-HCC.
Dr Amit G Singal led the team of 20 specialists.
It helps doctors study each tumor more closely.
They can look at the tumor’s biology, medical scans, and whether it has reached blood vessels.
This information may help doctors choose among surgery, medicines, radiation, or other treatments.
The guide is not a new medicine or procedure.
Finding liver cancer early is still important because some early cancers can be removed or destroyed and may be cured.
Dr Amit G Singal led 20 North American liver cancer specialists in developing BEACON-HCC.
The framework was published in the journal Hepatology in August.
BEACON-HCC helps doctors assess treatments using tumor biology, scans, and blood-vessel involvement.
It organizes existing and emerging treatments rather than introducing a new therapy.
Early diagnosis remains crucial because curative options are generally available only before advanced disease.
- Who
- Dr Amit G Singal and 19 other North American liver cancer specialists.
- What
- They developed BEACON-HCC, a framework to help doctors decide how to treat hepatocellular carcinoma.
- Where
- The framework was developed by North American specialists and published in the journal Hepatology.
- When
- The framework was published in Hepatology in August; the articles do not specify the year.
- Why
- Treatments for hepatocellular carcinoma are expanding rapidly, but there is no universal system for selecting among them.
Key facts
- Framework
- BEACON-HCC, meaning Best Evidence and North American Consensus on Hepatocellular Carcinoma.
- Lead researcher
- Dr Amit G Singal, professor of Internal Medicine at UT Southwestern and chief of hepatology.
- Team
- 20 North American liver cancer specialists.
- Publication
- The framework was published in the journal Hepatology in August.
- Disease
- Hepatocellular carcinoma, a form of liver cancer.
- Approach
- The framework considers tumor biology, CT and MRI findings, and whether cancer has spread into blood vessels.
- Treatment status
- BEACON-HCC is a decision-making framework, not a new treatment.
Quotes
Dr Amit G Singal
Lead researcher, Indian-origin hepatology professor at UT Southwestern
““This is a disease that continues to have a poor prognosis, and we clearly need to do better. BEACON‑HCC is an important step in that direction.””
theprint.in
Sources
Related news
Manipal Hospital Urges Early Screening to Protect Liver Health
UCLA's MethylScan Blood Test Shows Promise Detecting Cancer, Liver Disease
Man Dies After Rare Cancer Misdiagnosed as Muscle Pull
Influencer Sydney Towle, 26, Dies From Rare Bile Duct Cancer
